| Literature DB >> 34059956 |
Aja Louise Murray1, Daniel Nagin2, Ingrid Obsuth3, Denis Ribeaud4, Manuel Eisner4,5.
Abstract
Developmental trajectories of common mental health issues such as ADHD symptoms, internalising problems, and externalising problems can often be usefully summarised in terms of a small number of 'developmental subtypes' (e.g., 'childhood onset', 'adolescent onset') that may differ in their profiles or levels of clinically meaningful variables such as etiological risk factors. However, given the strong tendency for symptoms in these domains to co-occur, it is important to consider not only developmental subtypes in each domain individually, but also the joint developmental subtypes defined by symptoms trajectories in all three domains together (e.g., 'late onset multimorbid', 'pure internalising', 'early onset multimorbid'). Previous research has illuminated the joint developmental subtypes of ADHD symptoms, internalising problems, and externalising problems that emerge from normative longitudinal data using methods such as group-based trajectory modelling, as well as predictors of membership in these developmental subtypes. However, information on the long-term outcomes of developmental subtype membership is critical to illuminate the likely nature and intensity of support needs required for individuals whose trajectories fit different developmental subtypes. We, therefore, evaluated the relations between developmental subtypes previously derived using group-based trajectory modelling in the z-proso study (n = 1620 with trajectory data at ages 7, 8, 9, 10, 11, 12, 13, 15) and early adulthood outcomes. Individuals with multimorbid trajectories but not 'pure' internalising problem elevations showed higher levels of social exclusion and delinquency at age 20. These associations held irrespective of the specific developmental course of symptoms (e.g., early versus late onset versus remitting). There was also some evidence that intimate partner violence acts as a form of heterotypic continuity for earlier externalising problems. Results underline the need for early intervention to address the pathways that lead to social exclusion and delinquency among young people with multiple co-occurring mental health issues.Entities:
Keywords: ADHD; Comorbidity; Externalising problems; Group-based trajectory modelling; Internalising problems
Mesh:
Year: 2021 PMID: 34059956 PMCID: PMC9470602 DOI: 10.1007/s10578-021-01193-8
Source DB: PubMed Journal: Child Psychiatry Hum Dev ISSN: 0009-398X
Fig. 1ADHD, internalising and externalising trajectories across ages 7–15
Descriptive statistics
| N | Mean | SD | Min | Max | Skew | Kurtosis | |
|---|---|---|---|---|---|---|---|
| ADHD age 7 | 1312 | 15.66 | 7.04 | 7.00 | 35.00 | 0.64 | − 0.40 |
| ADHD age 8 | 1305 | 14.59 | 6.91 | 7.00 | 35.00 | 0.81 | − 0.16 |
| ADHD age 9 | 1283 | 14.34 | 6.69 | 7.00 | 35.00 | 0.87 | 0.16 |
| ADHD age 10 | 1252 | 14.59 | 6.96 | 7.00 | 35.00 | 0.84 | − 0.11 |
| ADHD age 11 | 1053 | 14.31 | 6.97 | 7.00 | 35.00 | 0.89 | 0.02 |
| ADHD age 12 | 970 | 13.78 | 6.62 | 7.00 | 35.00 | 1.03 | 0.41 |
| ADHD age 13 | 1242 | 14.08 | 6.69 | 7.00 | 35.00 | 0.97 | 0.32 |
| ADHD age 15 | 1276 | 13.92 | 6.56 | 7.00 | 35.00 | 0.91 | 0.08 |
| Internalising age 7 | 1302 | 13.03 | 5.29 | 7.00 | 35.00 | 0.99 | 0.72 |
| Internalising age 8 | 1303 | 12.43 | 5.08 | 7.00 | 35.00 | 1.01 | 0.86 |
| Internalising age 9 | 1281 | 12.90 | 5.19 | 7.00 | 35.00 | 0.85 | 0.41 |
| Internalising age 10 | 1240 | 13.24 | 5.15 | 7.00 | 35.00 | 0.81 | 0.30 |
| Internalising age 11 | 1034 | 13.31 | 5.32 | 7.00 | 35.00 | 0.91 | 0.41 |
| Internalising age 12 | 967 | 13.19 | 5.39 | 7.00 | 35.00 | 0.97 | 0.74 |
| Internalising age 13 | 1232 | 13.13 | 5.33 | 7.00 | 35.00 | 0.95 | 0.75 |
| Internalising age 15 | 1265 | 13.09 | 5.27 | 7.00 | 35.00 | 0.92 | 0.48 |
| Externalising age 7 | 1263 | 25.08 | 9.62 | 17.00 | 74.00 | 1.72 | 3.01 |
| Externalising age 8 | 1266 | 24.67 | 9.08 | 17.00 | 64.00 | 1.58 | 2.36 |
| Externalising age 9 | 1240 | 25.20 | 9.45 | 17.00 | 68.00 | 1.68 | 3.07 |
| Externalising age 10 | 1213 | 24.28 | 9.48 | 17.00 | 72.00 | 1.85 | 3.64 |
| Externalising age 11 | 1039 | 23.75 | 8.78 | 17.00 | 69.00 | 1.84 | 3.44 |
| Externalising age 12 | 953 | 23.97 | 9.35 | 17.00 | 75.00 | 1.95 | 4.18 |
| Externalising age 13 | 1207 | 22.28 | 8.05 | 17.00 | 77.00 | 2.60 | 8.99 |
| Externalising age 15 | 1221 | 22.29 | 7.79 | 17.00 | 85.00 | 2.38 | 7.38 |
| Social exclusion age 20 | 1176 | 9.12 | 3.54 | 6.00 | 24.00 | 1.22 | 1.01 |
| Optimism age 20 | 1177.00 | 12.85 | 2.29 | 4.00 | 16.00 | − 0.67 | 0.32 |
| Subjective stress age 20 | 1180.00 | 11.28 | 3.72 | 4.00 | 20.00 | 0.31 | − 0.45 |
| Physical IPV perpetration age 20 | 774.00 | 6.36 | 1.03 | 6.00 | 19.00 | 5.24 | 41.66 |
| Sexual IPV perpetration age 20 | 774.00 | 4.04 | 0.29 | 4.00 | 8.00 | 8.64 | 86.06 |
| Psychological IPV perpetration age 20 | 773.00 | 3.54 | 0.99 | 3.00 | 12.00 | 2.75 | 11.56 |
| Monitoring IPV perpetration age 20 | 774.00 | 5.93 | 2.38 | 4.00 | 16.00 | 1.52 | 2.28 |
| Physical IPV victimisation age 20 | 774.00 | 6.57 | 1.35 | 6.00 | 18.00 | 3.86 | 20.16 |
| Sexual IPV victimisation age 20 | 775.00 | 4.18 | 0.72 | 4.00 | 12.00 | 6.05 | 45.20 |
| Psychological IPV victimisation age 20 | 772.00 | 3.91 | 1.47 | 3.00 | 12.00 | 2.15 | 5.31 |
| Monitoring IPV victimisation age 20 | 775.00 | 6.46 | 2.95 | 4.00 | 16.00 | 1.38 | 1.37 |
| Delinquency age 20 | 1174.00 | 2.47 | 2.19 | 0.00 | 13.00 | 1.54 | 3.29 |
Outcome analyses
| Group | Mean | SE | 95% CI lower | 95% CI upper |
|---|---|---|---|---|
| Unaffected | 9.94 | 0.26 | 9.44 | 10.45 |
| Internalising | 12.16 | 1.38 | 9.45 | 14.87 |
| Multimorbid late onset | 12.43 | 0.41 | 11.63 | 13.23 |
| Normative maturing | 12.45 | 0.88 | 10.72 | 14.18 |
| Multimorbid remitting | 12.33 | 0.48 | 11.38 | 13.27 |
| Multimorbid with remitting externalising | 12.81 | 0.75 | 11.35 | 14.28 |
| Unaffected | 12.96 | 0.28 | 12.41 | 13.51 |
| Internalising | 11.91 | 1.24 | 9.48 | 14.34 |
| Multimorbid late onset | 11.98 | 0.52 | 10.97 | 12.99 |
| Normative maturing | 11.70 | 0.79 | 10.16 | 13.24 |
| Multimorbid remitting | 12.15 | 0.59 | 11.00 | 13.30 |
| Multimorbid with remitting externalising | 12.11 | 0.41 | 11.31 | 12.92 |
| Unaffected | 11.19 | 0.37 | 10.46 | 11.93 |
| Internalising | 11.95 | 0.53 | 10.90 | 12.99 |
| Multimorbid late onset | 11.64 | 0.91 | 9.85 | 13.42 |
| Normative maturing | 12.16 | 0.86 | 10.47 | 13.84 |
| Multimorbid remitting | 11.89 | 0.35 | 11.21 | 12.57 |
| Multimorbid with remitting externalising | 12.14 | 0.59 | 10.98 | 13.29 |
| Unaffected | 6.99 | 0.30 | 6.40 | 7.58 |
| Internalising | 7.90 | 0.54 | 6.85 | 8.96 |
| Multimorbid late onset | 8.26 | 0.44 | 7.40 | 9.12 |
| Normative maturing | 7.93 | 0.47 | 7.00 | 8.85 |
| Multimorbid remitting | 8.00 | 0.19 | 7.63 | 8.38 |
| Multimorbid with remitting externalising | 8.25 | 0.42 | 7.44 | 9.07 |
| Unaffected | 4.20 | 0.29 | 3.63 | 4.76 |
| Internalising | 4.43 | 0.10 | 4.23 | 4.62 |
| Multimorbid late onset | 4.55 | 0.13 | 4.29 | 4.82 |
| Normative maturing | 4.44 | 0.16 | 4.13 | 4.75 |
| Multimorbid remitting | 4.51 | 0.15 | 4.21 | 4.80 |
| Multimorbid with remitting externalising | 4.54 | 0.19 | 4.16 | 4.93 |
| Unaffected | 3.82 | 0.23 | 3.36 | 4.28 |
| Internalising | 4.48 | 0.37 | 3.77 | 5.20 |
| Multimorbid late onset | 4.66 | 0.34 | 3.99 | 5.32 |
| Normative maturing | 4.49 | 0.47 | 3.57 | 5.41 |
| Multimorbid remitting | 4.57 | 0.33 | 3.93 | 5.21 |
| Multimorbid with remitting externalising | 4.86 | 0.25 | 4.36 | 5.35 |
| Unaffected | 6.54 | 0.28 | 5.99 | 7.09 |
| Internalising | 7.59 | 0.69 | 6.23 | 8.94 |
| Multimorbid late onset | 7.71 | 0.71 | 6.33 | 9.10 |
| Normative maturing | 7.45 | 0.64 | 6.20 | 8.70 |
| Multimorbid remitting | 7.58 | 0.70 | 6.21 | 8.94 |
| Multimorbid with remitting externalising | 8.00 | 0.77 | 6.48 | 9.52 |
| Unaffected | 7.44 | 0.51 | 6.45 | 8.43 |
| Internalising | 8.75 | 1.03 | 6.74 | 10.77 |
| Multimorbid late onset | 9.61 | 0.87 | 7.91 | 11.30 |
| Normative maturing | 8.95 | 0.95 | 7.09 | 10.80 |
| Multimorbid remitting | 9.44 | 0.53 | 8.40 | 10.47 |
| Multimorbid with remitting externalising | 10.00 | 0.87 | 8.30 | 11.69 |
| Unaffected | 4.71 | 0.38 | 3.97 | 5.44 |
| Internalising | 5.30 | 0.79 | 3.76 | 6.84 |
| Multimorbid late onset | 5.56 | 0.74 | 4.10 | 7.02 |
| Normative maturing | 5.41 | 0.49 | 4.44 | 6.38 |
| Multimorbid remitting | 5.48 | 0.49 | 4.53 | 6.44 |
| Multimorbid with remitting externalising | 5.82 | 0.44 | 4.96 | 6.68 |
| Unaffected | 4.26 | 0.23 | 3.81 | 4.72 |
| Internalising | 5.05 | 0.44 | 4.19 | 5.92 |
| Multimorbid late onset | 5.42 | 0.55 | 4.34 | 6.50 |
| Normative maturing | 5.14 | 0.47 | 4.22 | 6.06 |
| Multimorbid remitting | 5.49 | 0.44 | 4.63 | 6.35 |
| Multimorbid with remitting externalising | 5.68 | 0.33 | 5.03 | 6.32 |
| Unaffected | 6.87 | 0.24 | 6.39 | 7.34 |
| Internalising | 8.59 | 0.66 | 7.30 | 9.87 |
| Multimorbid late onset | 9.07 | 0.69 | 7.73 | 10.42 |
| Normative maturing | 8.54 | 0.66 | 7.24 | 9.84 |
| Multimorbid remitting | 8.86 | 0.61 | 7.66 | 10.06 |
| Multimorbid with remitting externalising | 9.13 | 0.76 | 7.63 | 10.62 |
| Unaffected | 4.82 | 0.44 | 3.95 | 5.68 |
| Internalising | 7.31 | 0.89 | 5.56 | 9.06 |
| Multimorbid late onset | 8.97 | 0.91 | 7.18 | 10.75 |
| Normative maturing | 7.33 | 0.49 | 6.38 | 8.28 |
| Multimorbid remitting | 7.74 | 0.57 | 6.62 | 8.86 |
| Multimorbid with remitting externalising | 7.94 | 0.96 | 6.05 | 9.82 |
Mean is across imputed datasets; standard errors (SEs) and associated 95% confidence intervals (CIs) are adjusted for between-imputation variation
Fig. 2Pooled mean and 95% confidence intervals for outcomes across the six trajectory groups